PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma

References

• Weterman MA, Wilbrink M, Geurts van Kessel A. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas. Proc Natl Acad Sci U S A. 1996;93(26):15294–15298.
   PubMed Web of Science ®Google Scholar
• de Jong B, Molenaar IM, Leeuw JA, et al. Cytogenetics of a renal adenocarcinoma in a 2-year-old child. Cancer Genet Cytogenet. 1986;21(2):165–169.
   PubMedGoogle Scholar
• Aksan I, Goding CR. Targeting the microphthalmia basic helix-loop-helix-leucine zipper transcription factor to a subset of E-box elements in vitro and in vivo. Mol Cell Biol. 1998;18(12):6930–6938.
   PubMed Web of Science ®Google Scholar
• Hemesath TJ, Steingrimsson E, McGill G, et al. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev. 1994;8(22):2770–2780.
   PubMed Web of Science ®Google Scholar
• Kauffman EC, Rickett CJ, Rais Bahrami S, et al. Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat Rev Urol. 2014;11(8):465–475.
   PubMed Web of Science ®Google Scholar
• Slade L, Pulinilkunnil T. The MiTF/TFE family of transcription factors: master regulators of organelle signaling, metabolism, and stress adaptation. Mol Cancer Res. 2017;15(12):1637–1643.
   PubMed Web of Science ®Google Scholar
• Raben N, Puertollano R. TFEB and TFE3: linking lysosomes to cellular adaptation to stress. Annu Rev Cell Dev Biol. 2016;32(1):255–278.
   PubMedGoogle Scholar
• Lemasters JJ. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res. 2005;8(1):3–5.
   PubMed Web of Science ®Google Scholar
• Eiyama A, Okamoto K. PINK1/Parkin-mediated mitophagy in mammalian cells. Curr Opin Cell Biol. 2015;33:95–101.
   PubMed Web of Science ®Google Scholar
• Kondapalli C, Kazlauskaite A, Zhang N, et al. PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65. Open Biol. 2012;25(5):2.
   Web of Science ®Google Scholar
• Lazarou M, Sliter DA, Kane LA, et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature. 2015;524(7565):309–314.
   PubMed Web of Science ®Google Scholar
• Nezich CL, Wang C, Fogel AI, et al. MiT/TFE transcription factors are activated during mitophagy downstream of Parkin and Atg5. J Cell Biol. 2015;210(3):435–450.
   PubMed Web of Science ®Google Scholar
• Baba M, Endoh M, Ma W, et al. Folliculin regulates osteoclastogenesis through metabolic regulation. J Bone Miner Res. 2018;33(10):1785–1798.
   PubMed Web of Science ®Google Scholar
• Salma N, Song JS, Arany Z. Transcription factor Tfe3 directly regulates Pgc‐1alpha in muscle. J Cell Physiol. 2015;230(10):2330–2336.
   PubMed Web of Science ®Google Scholar
• Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24(5):981–990.
   PubMed Web of Science ®Google Scholar
• Porporato PE, Filigheddu N, Pedro JMB, et al. Mitochondrial metabolism and cancer. Cell Res. 2018;28(3):265–280.
   PubMed Web of Science ®Google Scholar
• Cheng CW, C Y K, Fan CC. Overexpression of Lon contributes to survival and aggressive phenotype of cancer cells through mitochondrial complex I-mediated generation of reactive oxygen species. Cell Death Dis. 2013;4(6):e681.
   PubMedGoogle Scholar
• Kubli DA, Gustafsson AB. Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res. 2012;111(9):1208–1221.
   PubMed Web of Science ®Google Scholar
• Idelchik M, Begley U, Begley TJ, et al. Mitochondrial ROS control of cancer. Semin Cancer Biol. 2017;47:57–66.
   PubMed Web of Science ®Google Scholar
• Le Gal K, Ibrahim MX, Wiel C, et al. Antioxidants can increase melanoma metastasis in mice. Sci Transl Med. 2015;7(308):308re8.
   PubMed Web of Science ®Google Scholar
• Piskounova E, Agathocleous M, Murphy MM, et al. Oxidative stress inhibits distant metastasis by human melanoma cells. Nature. 2015;527(7577):186–191.
   PubMed Web of Science ®Google Scholar
• Sayin VI, Ibrahim MX, Larsson E, et al. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med. 2014;6(221):221ra15.
   PubMed Web of Science ®Google Scholar
• Xiao D, Powolny AA, Moura MB, et al. Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J Biol Chem. 2010;285(34):26558–26569.
   PubMed Web of Science ®Google Scholar
• Xiao B, Deng X, Lim GGY, et al. Superoxide drives progression of Parkin/PINK1-dependent mitophagy following translocation of Parkin to mitochondria. Cell Death Dis. 2017;8(10):e3097.
   PubMedGoogle Scholar
• Wang Y, Nartiss Y,  Steipe B, et al. ROS-induced mitochondrial depolarization initiates PARK2/PARKIN-dependent mitochondrial degradation by autophagy. Autophagy. 2012;8(10):1462–1476.
   PubMed Web of Science ®Google Scholar
• Simon HU, Haj-Yehia A. Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis. 2000;5(5):415–418.
   PubMed Web of Science ®Google Scholar
• Xu L, Lin DC, Yin D, et al. An emerging role of PARK2 in cancer. J Mol Med (Berl). 2014;92(1):31–42.
   PubMed Web of Science ®Google Scholar
• Wang H, Song P, Du L, et al. Parkin ubiquitinates Drp1 for proteasome-dependent degradation: implication of dysregulated mitochondrial dynamics in parkinson disease. J Biol Chem. 2011;286(13):11649–11658.
   PubMed Web of Science ®Google Scholar
• Florey O, Gammoh N, Kim SE, et al. V-ATPase and osmotic imbalances activate endolysosomal LC3 lipidation. Autophagy. 2015;11(1):88–99.
   PubMed Web of Science ®Google Scholar
• Jacquin E, Leclerc-Mercier S, Judon C, et al. Pharmacological modulators of autophagy activate a parallel noncanonical pathway driving unconventional LC3 lipidation. Autophagy. 2017;13(5):854–867.
   PubMed Web of Science ®Google Scholar
• Takahashi D, Moriyama J, Nakamura T, et al. AUTACs: cargo-specific degraders using selective autophagy. Mol Cell. 2019;76(5):797–810 e10.
   PubMed Web of Science ®Google Scholar
• Namba T. BAP31 regulates mitochondrial function via interaction with Tom40 within ER-mitochondria contact sites. Sci Adv. 2019;5(6):eaaw1386.
   PubMed Web of Science ®Google Scholar
• Zheng J, Croteau DL,  Bohr VA, et al. Diminished OPA1 expression and impaired mitochondrial morphology and homeostasis in aprataxin-deficient cells. Nucleic Acids Res. 2019;47(8):4086–4110.
   PubMed Web of Science ®Google Scholar
• Skalsky YM, Ajuh PM, Parker C, et al. PRCC, the commonest TFE3 fusion partner in papillary renal carcinoma is associated with pre-mRNA splicing factors. Oncogene. 2001;20(2):178–187.
   PubMed Web of Science ®Google Scholar
• Weterman MAJ, van Groningen JJ, Jansen A, et al. Nuclear localization and transactivating capacities of the papillaryrenal cell carcinoma-associated TFE3 and PRCC (fusion) proteins. Oncogene. 2000;19(1):69–74.
   PubMed Web of Science ®Google Scholar
• Yin X, Wang B, Gan W, et al. TFE3 fusions escape from controlling of mTOR signaling pathway and accumulate in the nucleus promoting genes expression in Xp11.2 translocation renal cell carcinomas. J Exp Clin Cancer Res. 2019;38(1):119.
   PubMedGoogle Scholar
• West AB, Kapatos G, O’Farrell C, et al. N-myc regulates parkin expression. J Biol Chem. 2004;279(28):28896–28902.
   PubMed Web of Science ®Google Scholar
• Betschinger J, Nichols J, Dietmann S, et al. Exit from pluripotency is gated by intracellular redistribution of the bHLH transcription factor Tfe3. Cell. 2013;153(2):335–347.
   PubMed Web of Science ®Google Scholar
• Pastore N, Vainshtein A, Klisch TJ, et al. TFE3 regulates whole-body energy metabolism in cooperation with TFEB. EMBO Mol Med. 2017;9(5):605–621.
   PubMed Web of Science ®Google Scholar
• Raben N, Puertollano R. TFEB and TFE3: linking Lysosomes to Cellular Adaptation to Stress. Annu Rev Cell Dev Biol. 2016;32(32):255–278.
   PubMedGoogle Scholar
• Fernandez-Marcos PJ, Auwerx J. Regulation of PGC-1alpha, a nodal regulator of mitochondrial biogenesis. Am J Clin Nutr. 2011;93(4):884S–90.
   PubMed Web of Science ®Google Scholar
• Satoh J, Kawana N, Yamamoto Y. Pathway analysis of ChIP-Seq-based NRF1 target genes suggests a logical hypothesis of their involvement in the pathogenesis of neurodegenerative diseases. Gene Regul Syst Bio. 2013;7:139–152.
   PubMedGoogle Scholar
• Hernandez G, Thornton C, Stotland A, et al. MitoTimer: a novel tool for monitoring mitochondrial turnover. Autophagy. 2013;9(11):1852–1861.
   PubMed Web of Science ®Google Scholar
• Dolman NJ, Chambers KM, Mandavilli B, et al. Tools and techniques to measure mitophagy using fluorescence microscopy. Autophagy. 2014;9(11):1653–1662.
   Web of Science ®Google Scholar
• Li Y, Qin Y, Yang C, et al. Cardamonin induces ROS-mediated G2/M phase arrest and apoptosis through inhibition of NF-kappaB pathway in nasopharyngeal carcinoma. Cell Death Dis. 2017;8(8):e3024.
   PubMedGoogle Scholar
• Martina JA, Diab HI, Lishu L, et al. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci Signal. 2014;7(309):ra9–ra9.
   PubMed Web of Science ®Google Scholar
• Argani P, Zhong M, Reuter VE, et al. TFE3-fusion variant analysis defines specific clinicopathologic associations among Xp11 translocation cancers. Am J Surg Pathol. 2016;40(6):723–737.
   PubMed Web of Science ®Google Scholar
• Ellis CL, Eble JN, Subhawong AP, et al. Clinical heterogeneity of Xp11 translocation renal cell carcinoma: impact of fusion subtype, age, and stage. Mod Pathol. 2014;27(6):875–886.
   PubMed Web of Science ®Google Scholar
• Yin Q, Jian Y,  Xu M, et al. CDK4/6 regulate lysosome biogenesis through TFEB/TFE3. J Cell Biol. 2020;219(8):e201911036.
   Web of Science ®Google Scholar
• Bouman L, Schlierf A, Lutz AK, et al. Parkin is transcriptionally regulated by ATF4: evidence for an interconnection between mitochondrial stress and ER stress. Cell Death Differ. 2011;18(5):769–782.
   PubMed Web of Science ®Google Scholar
• Tran TA, Nguyen AD, Chang J, et al. Lipopolysaccharide and tumor necrosis factor regulate Parkin expression via nuclear factor-kappa B. PLoS One. 2011;6(8):e23660.
   PubMed Web of Science ®Google Scholar
• Zhang W, Hu X, Shen Q, et al. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy. Nat Commun. 2019;10(1):1704.
   PubMedGoogle Scholar
• Gupta P, Wright SE,  Kim SH, et al. Phenethyl isothiocyanate: a comprehensive review of anti-cancer mechanisms. Biochim Biophys Acta. 2014;1846(2):405–424.
   PubMed Web of Science ®Google Scholar
• Chen G, Chen Z, Hu Y, et al. Inhibition of mitochondrial respiration and rapid depletion of mitochondrial glutathione by beta-phenethyl isothiocyanate: mechanisms for anti-leukemia activity. Antioxid Redox Signal. 2011;15(12):2911–2921.
   PubMed Web of Science ®Google Scholar
• Pustylnikov S, Costabile F, Beghi S, et al. Targeting mitochondria in cancer: current concepts and immunotherapy approaches. Transl Res. 2018;202:35–51.
   PubMed Web of Science ®Google Scholar
• Picchio MC, Martin ES, Cesari R. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res. 2004;10(8):2720–2724.
   PubMed Web of Science ®Google Scholar
• Toma MI, Grosser M, Herr A. Loss of heterozygosity and copy number abnormality in clear cell renal cell carcinoma discovered by high-density affymetrix 10K single nucleotide polymorphism mapping array. Neoplasia. 2008;10(7):634–642.
   PubMed Web of Science ®Google Scholar
• Yeo CW, Ng FSL, Chai C, et al. Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival. Cancer Res. 2012;72(10):2543–2553.
   PubMed Web of Science ®Google Scholar